Skip to main content Back to Top
Advertisement

5/15/2019

Sodium Polystyrene Sulfonate Powder

Products Affected - Description

    • Sodium Polystyrene Sulfonate powder for suspension, CMP Pharma, 454 gram, bottle, NDC 46287-0012-16
    • Sodium Polystyrene Sulfonate powder for suspension, ECI Pharmaceuticals, 454 gram, bottle, NDC 51293-0831-97
    • Sodium Polystyrene Sulfonate powder for suspension, Sunrise, 15 gram, bottle, 10 count, NDC 11534-0166-15
    • Sodium Polystyrene Sulfonate powder for suspension, Sunrise, 454 gram, bottle, NDC 11534-0166-44
    • Sodium Polystyrene Sulfonate powder for suspension, Trigen, 454 gram, bottle, NDC 13811-0656-53

Reason for the Shortage

    • CMP Pharma has sodium polystyrene sulfonate on back order due to a raw material shortage. They are using available powder to make suspension.
    • ECI Pharmaceuticals did not provide a reason for the shortage.
    • KVK-Tech did not provide a reason for the shortage.
    • Sunrise Pharmaceuticals has sodium polystyrene sulfonate on back order due to a raw material shortage.
    • Trigen did not provide a reason for the shortage.

Available Products

    • Sodium Polystyrene Sulfonate powder for suspension, KVK-Tech, 15 gram, bottle, 12 count, NDC 10702-0036-15
    • Sodium Polystyrene Sulfonate powder for suspension, KVK-Tech, 454 gram, bottle, NDC 10702-0036-45

Estimated Resupply Dates

    • CMP Pharma has sodium polystyrene sulfonate in 454 gram bottles on back order and the company cannot estimate a release date.
    • ECI Pharmaceuticals has sodium polystyrene sulfonate in 454 gram bottles on allocation.
    • Sunrise Pharmaceuticals has sodium polystyrene sulfonate in 15 gram and 454 gram bottles on intermittent back order and the company cannot estimate release dates.
    • Trigen has sodium polystyrene sulfonate in 454 gram bottles on allocation.

Updated

Updated May 15, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 22, 2019 by Stephen Andrews, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins